Back to User profile » Dr Xi-Jing Wang
Papers published by Dr Xi-Jing Wang:
Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese women
Wang M, Wang Z, Wang XJ, Jin TB, Dai ZM, Kang HF, Guan HT, Ma XB, Liu XH, Dai ZJ
Drug Design, Development and Therapy 2016, 10:2359-2367
Published Date: 25 July 2016
PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk
Wang M, Wang XJ, Ma YF, Ma XB, Dai ZM, Lv Y, Lin S, Liu XH, Yang PT, Dai ZJ
Therapeutics and Clinical Risk Management 2015, 11:237-245
Published Date: 13 February 2015
Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls
Gao J, Kang AJ, Lin S, Dai ZJ, Zhang SQ, Liu D, Zhao Y, Yang PT, Wang M, Wang XJ
Therapeutics and Clinical Risk Management 2014, 10:269-277
Published Date: 15 April 2014